Alexey Goltsov
Impact in
- Biophysics top 10%
-
- Gene Regulatory Network Analysis
- Bioinformatics and Genomic Networks
- Genomics, phytochemicals, and oxidative stress
- PI3K/AKT/mTOR signaling in cancer
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 4
- Gene Regulatory Network Analysis 4
- Lipid Membrane Structure and Behavior 3
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Simon P. Langdon (11 shared papers)David J. Harrison (12 shared papers)James Bown (13 shared papers)Igor Goryanin (8 shared papers)Dana Faratian (5 shared papers)Edik U. Rafailov (5 shared papers)Sergei G. Sokolovski (5 shared papers)Peter Mullen (4 shared papers)
- Journals
- European Journal of Pharmaceutical Sciences (3 papers)Cellular Signalling (3 papers)Journal of Biotechnology (2 papers)Pharmaceuticals (2 papers)Oncotarget (2 papers)
- Partner nations
- United KingdomRussiaUnited States
In The Last Decade
Alexey Goltsov
38 papers receiving 552 citations
Peers
Comparison fields: 5 of 106
- Biophysics 30
- Molecular Biology 323
- Radiology, Nuclear Medicine and Imaging 105
- Modeling and Simulation 19
- Oncology 96
Countries citing papers authored by Alexey Goltsov
This map shows the geographic impact of Alexey Goltsov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexey Goltsov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexey Goltsov more than expected).
Fields of papers citing papers by Alexey Goltsov
This network shows the impact of papers produced by Alexey Goltsov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexey Goltsov. The network helps show where Alexey Goltsov may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexey Goltsov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 126 | |
| 2 | 2013 | 57 | |
| 3 | 2011 | 35 | |
| 4 | 2014 | 33 | |
| 5 | 2016 | 26 | |
| 6 | 2017 | 25 | |
| 7 | 2017 | 23 | |
| 8 | 2014 | 21 | |
| 9 | 2010 | 19 | |
| 10 | 2019 | 17 | |
| 11 | 2008 | 17 | |
| 12 | 2000 | 16 | |
| 13 | 2012 | 15 | |
| 14 | 2013 | 15 | |
| 15 | 2011 | 13 | |
| 16 | 1999 | 11 | |
| 17 | 2014 | 10 | |
| 18 | 2012 | 10 | |
| 19 | 2022 | 9 | |
| 20 | 2022 | 7 |
About Alexey Goltsov
Alexey Goltsov is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Atomic and Molecular Physics, and Optics, Oncology and Biomedical Engineering, having authored 39 papers that have together received 567 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Spectroscopy and Quantum Chemical Studies (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Gene Regulatory Network Analysis (4 papers), Nanoplatforms for cancer theranostics (3 papers), HER2/EGFR in Cancer Research (3 papers), Lipid Membrane Structure and Behavior (3 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Biophysics (30 citations), Molecular Biology (323 citations), Radiology, Nuclear Medicine and Imaging (105 citations), Modeling and Simulation (19 citations) and Oncology (96 citations). Alexey Goltsov has collaborated with scholars based in United Kingdom, Russia and United States. Frequent co-authors include Simon P. Langdon, David J. Harrison, James Bown, Igor Goryanin, Dana Faratian, Edik U. Rafailov, Sergei G. Sokolovski, Peter Mullen, Anatoly Sorokin and Yusuf Deeni. Their work appears in journals such as European Journal of Pharmaceutical Sciences, Cellular Signalling, Journal of Biotechnology, Pharmaceuticals and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.